Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Colorado MEDtech, CMED -- Ignore unavailable to you. Want to Upgrade?

To: Rooster Cogburn who wrote (152)	12/1/1998 6:28:00 PM
From: Paul K	Respond to of 288

TAVA's Medical Product Licencee Shows Growing Backlog PR Newswire - December 01, 1998 14:50 ENGLEWOOD, Colo., Dec. 1 /PRNewswire/ -- TAVA Technologies (Nasdaq: TAVA) a leading provider of automation and information technology solutions to industry, announced today that the company expects to receive initial license revenues from its licensee, BioMed Y2K, a subsidiary of Colorado MEDtech, Inc. (Nasdaq: CMED), in the quarter ending December 31, 1998. Earlier this year, TAVA licensed its PlantY2kOne product technology to BioMed Y2K. BioMed Y2K used that technology to develop a suite of products designed specifically to address year 2000 compliance issues in embedded technology found in biomedical devices used in hospitals, clinics, and extended care facilities. John Jenkins, TAVA CEO said." We are pleased to see this market for our technology beginning to develop. The BioMed people have built a good product and offer this market an important service as is evident by their project awards at The Cleveland Clinic and Westchester County Hospital among others." TAVA (www.tavatech.com) provides factory automated and control systems integration helping clients in manufacturing and process industries integrate their processes, applications, hardware and software into seamless manufacturing enterprises. Located in 14 regional offices throughout the U.S., TAVA has a staff of more than 550. Statements made in this Press Release that are not historical or current facts are "forward looking statements" made pursuant to the safe harbor provisions of federal securities laws. Forward-looking statements represent management's best judgment as to what may occur in the future, but are subject to certain risks and uncertainties that could cause actual results and events to differ materially from those presently anticipated or projected. Such factors include adverse economic conditions, entry of new and stronger competitors, inadequate capital, unexpected costs, failure to integrate operations of recently acquired subsidiaries and failure to capitalize upon access of new clientele. Specific risks and uncertainties which may affect forward-looking statements about the Company's Plant Y2K One(TM)business and prospects include the possibility that a competitor will develop a more comprehensive or less expensive Y2K solution, and delays in market awareness of Tava and its product and service solutions. These factors and others are discussed in the "Management's Discussion and Analysis" section of the Company's Annual Report on Form 10-KSB for the fiscal year ended June 30, 1997, to which reference should be made. SOURCE TAVA Technologies /CONTACT: John Jenkins, CEO or Doug Kelsall, CFO, both of TAVA Technologies, 303-771-9794; or Scott Liolios of Pacific Consulting Group, Inc., 949-574-3860/ /Web site: tavatech.com (TAVA CMED)